Macrocephaly-capillary malformation
A genetic disorder characterized by overgrowth and vascular anomalies
Macrocephaly-capillary malformation | |
---|---|
![]() | |
Synonyms | Macrocephaly-cutis marmorata telangiectatica congenita syndrome, Megalencephaly-cutis marmorata telangiectatica congenita syndrome, M-CM syndrome, MCAP |
Pronounce | |
Field | Medical genetics, Pediatrics, Neurology |
Symptoms | Macrocephaly, capillary malformations, developmental delay, hypotonia, connective tissue abnormalities, asymmetry, brain overgrowth, polymicrogyria, syndactyly |
Complications | Seizures, intellectual disability, overgrowth syndromes, risk of hydrocephalus |
Onset | Congenital |
Duration | Lifelong |
Types | Overgrowth syndrome |
Causes | Somatic mutations in the PIK3CA gene |
Risks | Sporadic; not usually inherited |
Diagnosis | Clinical examination, MRI, genetic testing |
Differential diagnosis | Klippel–Trénaunay syndrome, Proteus syndrome, Sturge–Weber syndrome, other PIK3CA-related overgrowth spectrum conditions |
Prevention | None |
Treatment | Supportive and symptomatic; includes physical therapy, occupational therapy, seizure management |
Medication | Anticonvulsants for seizures; investigational targeted therapies (e.g. PI3K inhibitors) |
Prognosis | Variable; depends on severity of symptoms and complications |
Frequency | Rare; estimated fewer than 1 in 1,000,000 live births |
Deaths | Rare; typically related to neurological complications |
Macrocephaly-capillary malformation (M-CM) is a rare genetic disorder characterized by a combination of macrocephaly, capillary malformation, and other distinctive features. It is also known as macrocephaly-capillary malformation syndrome (M-CM syndrome) or macrocephaly-cutis marmorata telangiectatica congenita (M-CMTC).
Clinical Features[edit | edit source]
Individuals with M-CM typically present with a range of clinical features, which may vary in severity. The hallmark features include:
- Macrocephaly: An abnormally large head size, often present at birth or developing in early infancy.
- Capillary malformations: These are flat, pink or red birthmarks, often referred to as "port-wine stains," that can occur anywhere on the body.
- Overgrowth: Disproportionate overgrowth of one side of the body (hemihyperplasia) or generalized overgrowth.
- Developmental delay: Many individuals experience delays in reaching developmental milestones.
- Hypotonia: Decreased muscle tone, which can affect motor skills.
- Syndactyly: Fusion of fingers or toes, which may be partial or complete.
- Polydactyly: Extra fingers or toes.
- Connective tissue abnormalities: Such as joint hypermobility or skin laxity.
Genetics[edit | edit source]
M-CM is caused by mutations in the PIK3CA gene, which plays a role in cell growth and division. These mutations are typically not inherited but occur as a de novo event, meaning they arise spontaneously in the affected individual. The condition is part of a group of disorders known as PIK3CA-related overgrowth spectrum (PROS).
Diagnosis[edit | edit source]
Diagnosis of M-CM is based on clinical evaluation and the presence of characteristic features. Genetic testing can confirm the diagnosis by identifying mutations in the PIK3CA gene. Imaging studies, such as MRI or CT scan, may be used to assess brain structure and identify any associated abnormalities.
Management[edit | edit source]
There is no cure for M-CM, and treatment is symptomatic and supportive. Management may involve:
- Regular monitoring of head growth and development.
- Physical and occupational therapy to address motor delays and hypotonia.
- Surgical intervention for syndactyly or polydactyly if necessary.
- Educational support for developmental delays.
- Monitoring for potential complications, such as seizures or hydrocephalus.
Prognosis[edit | edit source]
The prognosis for individuals with M-CM varies depending on the severity of symptoms and associated complications. Early intervention and supportive therapies can improve quality of life and developmental outcomes.
Related pages[edit | edit source]
External links[edit | edit source]
Classification | |
---|---|
External resources |
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD